• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[卵巢透明细胞腺癌的临床形态学特征]

[Clinico-morphological characteristics of light-cell adenocarcinoma of the ovaries].

作者信息

Ermilova V D, Korolenkova L I

出版信息

Arkh Patol. 1982;44(12):17-23.

PMID:7165529
Abstract

Clinical and morphological data on 37 observations of a rare neoplasm, clear-cell adenocarcinoma of the ovaries (CAO), are presented. Studies of the microstructure permitted the authors to distinguish 4 histological variants: tubular, papillary, solid, and mixed. Comparison of the data on the three-year survival rate with different histological variants of the tumor in all stages and within stage I revealed a higher survival rate in patients with the tubular variant of CAO which is considered to be more favourable prognostically. The data of 3-year survival rate of all the patients (32.8 +/- 7.9%), and of those in stage I, with the tubular variant (88.9 +/- 10.5%), papillary and mixed variants taken together (23 +/- 11.5%), are presented. In the latter the survival rate is much lower than in the tubular variant of the tumor. The variant of the CAO microstructure should be included into the diagnosis.

摘要

本文呈现了37例罕见肿瘤——卵巢透明细胞腺癌(CAO)的临床和形态学数据。通过对微观结构的研究,作者区分出4种组织学变体:管状、乳头状、实性和混合型。对所有分期及I期内不同组织学变体肿瘤的三年生存率数据进行比较后发现,CAO管状变体患者的生存率更高,这在预后方面被认为更有利。文中给出了所有患者(32.8±7.9%)以及I期患者中管状变体(88.9±10.5%)、乳头状和混合型变体患者(23±11.5%)的三年生存率数据。在后者中,生存率远低于肿瘤的管状变体。CAO微观结构变体应纳入诊断。

相似文献

1
[Clinico-morphological characteristics of light-cell adenocarcinoma of the ovaries].[卵巢透明细胞腺癌的临床形态学特征]
Arkh Patol. 1982;44(12):17-23.
2
Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages.透明细胞上皮性卵巢癌(中肾样型):仅在早期预后较差。
Gynecol Oncol. 1993 May;49(2):250-4. doi: 10.1006/gyno.1993.1117.
3
Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.卵巢囊性及腺纤维瘤样透明细胞癌:发病机制和行为不同的独特肿瘤——122例临床病理分析
Am J Surg Pathol. 2009 Jun;33(6):844-53. doi: 10.1097/PAS.0b013e31819c4271.
4
[Clinical characteristics of clear cell carcinoma of the ovary].[卵巢透明细胞癌的临床特征]
Zhonghua Fu Chan Ke Za Zhi. 2002 Mar;37(3):161-3.
5
[Survival of cervical cancer patients in selected regions of Poland in 1990-1996, in relation to some prognostic factors].[1990 - 1996年波兰特定地区宫颈癌患者的生存情况与某些预后因素的关系]
Przegl Epidemiol. 2004;58(3):523-36.
6
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.手术细胞减灭术对IV期上皮性卵巢癌生存的影响。
Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145.
7
Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.人激肽释放酶8(hK8/TADG-14)的表达与卵巢癌的早期临床分期及良好预后相关。
Oncol Rep. 2004 Jun;11(6):1153-9.
8
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.与其他上皮细胞类型相比,透明细胞卵巢癌的预后是否更差?一项对1411例透明细胞卵巢癌的研究。
Gynecol Oncol. 2008 Jun;109(3):370-6. doi: 10.1016/j.ygyno.2008.02.006. Epub 2008 Apr 18.
9
Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.卵巢透明细胞癌的临床特征:一种预后不良且对铂类化疗耐药的独特组织学类型。
Cancer. 2000 Jun 1;88(11):2584-9.
10
From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.从克鲁肯伯格瘤到如今:卵巢转移性肿瘤带来的长期存在的问题。第二部分。
Adv Anat Pathol. 2007 May;14(3):149-77. doi: 10.1097/PAP.0b013e3180504abf.